Skip to content

Effect of Photobiomodulation and Enamel-Derived Matrix Proteins on Bone Repair in Maxillary Sinuses grafted with Deproteinized Bovine Bone

Effect of Photobiomodulation and Enamel-Derived Matrix Proteins on Bone Repair in Maxillary Sinuses grafted with Deproteinized Bovine Bone - A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-10nyxwkr
Enrollment
Unknown
Registered
2023-10-19
Start date
2023-12-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maxillary Sinus

Interventions

This is a randomized, controlled, trial in a parallel and single-blind model. The evaluating researcher will not have knowledge about the group to which the patient belongs. Forty-eight patients will
2) PBMT Group: Deproteinized bovine bone + Irradiation of the grafted area with laser at red and infrared wavelengths in the baseline periods, 3 and 7 days after the surgical procedure
3) EMD Group: Deproteinized bovine bone + EMD
4) PBMT+EMD Group: Deproteinized bovine bone + Irradiation of the grafted area with laser at red and infrared wavelengths in the baseline periods, 3 and 7 days after the surgical procedure + EMD. Pati
E02.594
D12.776.231

Sponsors

Universidade Federal de Uberlândia
Lead Sponsor
Universidade Federal de Uberlândia
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The patient required to present between 18 and 60 years old. need unilateral or bilateral elevation of the floor of the maxillary sinus for subsequent installation of osseointegrated implants. present bone availability associated with the alveolar ridge adjacent to the maxillary sinus less than or equal to 3mm. present good systemic health. present at least less than 4 months of healing of the socket after tooth extraction

Exclusion criteria

Exclusion criteria: Smokers. decompensated diabetics. patients with chronic or aggressive periodontitis. patients who use drugs that alter bone metabolism. patients who have chronic infections of the upper airways. patients who chronically use anti-inflammatory drugs and antibiotics. people with bruxism. alcoholics. drug addicts. pregnant women or who wish to become pregnant in the next year. history of radiotherapy treatment in the head and neck region. patients with pathologies that affect bone metabolism. patients who have had a major disruption of the sinus membrane during surgery

Design outcomes

Primary

MeasureTime frame
The application of dual-wavelength laser therapy and enamel matrix-derived protein will increase bone formation by 15% in maxillary sinuses grafted with deproteinized bovine bone compared to the isolated use of this graft.

Secondary

MeasureTime frame
The application of dual-wavelength laser therapy and protein derived from the enamel matrix will increase the volume of mineralized tissues in maxillary sinuses grafted with deproteinized bovine bone by 10% compared to the isolated use of this graft.;Implants placed in areas of maxillary sinuses grafted with deproteinized bovine bone treated with dual-wavelength laser therapy and with protein derived from the enamel matrix will have a success rate 10% higher than in areas grafted with deproteinized bovine bone in adjunctive treatment

Countries

Brazil

Contacts

Public ContactGuilherme Oliveira

Universidade Federal de Uberlândia

guilherme.lopesoliveira@ufu.br+55(34)32258132

Outcome results

None listed

Source: REBEC (via WHO ICTRP)